Nicotinyl riboside compounds and their uses
US-12178827-B2 · Dec 31, 2024 · US
US9913854B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9913854-B2 |
| Application number | US-201314388685-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 14, 2013 |
| Priority date | Mar 28, 2012 |
| Publication date | Mar 13, 2018 |
| Grant date | Mar 13, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided herein are methods for inducing cell death in a gram positive bacterium and methods for reducing the proliferation of a gram positive bacterium that include contacting a gram positive bacterium with a dye (e.g., an azo dye) and a TarO inhibitor. Also provided are methods of treating a subject having a gram positive bacterial infection that include administering to a subject having a gram positive bacterial infection a dye (e.g., an azo dye) and a TarO inhibitor. Also provided are compositions containing a dye (e.g., an azo dye) and a TarO inhibitor, and kits containing at least one of these compositions.
Opening claim text (preview).
The invention claimed is: 1. A method for inducing cell death in a gram positive bacterium or reducing the proliferation of a gram positive bacterium, the method comprising contacting a gram positive bacterium with Congo Red and tunicamycin in amounts sufficient to induce cell death in the gram positive bacterium or amounts sufficient to reduce the proliferation of the gram positive bacterium. 2. The method of claim 1 , wherein the gram positive bacterium is present in a mammal. 3. The method of claim 1 , wherein the gram positive bacterium is present in vitro. 4. The method of claim 3 , wherein the gram positive bacterium is present in a cell culture, is present in or on a food composition, or is present in a pharmaceutical or cosmetic composition. 5. The method of claim 1 , wherein the gram positive bacterium is a coccus gram positive bacterium. 6. The method of claim 5 , wherein the coccus gram positive bacterium is from the Streptococcus, Enterococcus , or Staphylococcus genus. 7. The method of claim 1 , wherein the gram positive bacterium is a bacillus gram positive bacterium. 8. The method of claim 7 , wherein the bacillus gram positive bacterium is from the Cornebacterium, Listeria, Bacillus , or Clostridium genus. 9. A method of treating a subject having a gram positive bacterial infection, the method comprising administering to the subject having a gram positive bacterial infection Congo Red and tunicamycin in amounts sufficient to decrease the population of gram positive bacteria in the subject. 10. The method of claim 9 , wherein the population of gram positive bacteria comprises coccus gram positive bacteria. 11. The method of claim 10 , wherein the coccus gram positive bacteria are from the Streptococcus, Enterococcus , or Staphylococcus genus. 12. The method of claim 9 , wherein the population of gram positive bacteria comprises bacillus gram positive bacteria. 13. The method of claim 12 , wherein the bacillus gram positive bacteria are from the Cornebacterium, Listeria, Bacillus , or Clostridium genus. 14. The method of claim 1 , wherein the concentration of Congo Red is less than 1024 mg/L. 15. The method of claim 9 , wherein the amount of the tunicamycin is not toxic to the subject.
Amino-benzenes · CPC title
from other coupling components · CPC title
Dye preparations of special physical nature; Tablets, films, extrusion, microcapsules, sheets, pads, bags with dyes · CPC title
Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds · CPC title
containing three or more hetero rings · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.